LFF
ARKG icon

Level Four Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

Level Four Financial’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$299K Buy
3,999
+114
+3% +$9.56K 0.13% 201
2021
Q2 		$359K Buy
3,885
+157
+4% +$13.3K 0.15% 187
2021
Q1 		$331K Buy
+3,728
New +$370K 0.15% 181

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Level Four Financial's ARKG Position: Q3 2021 in Review

Level Four Financial increased its ARK Genomic Revolution ETF (ARKG) stake by 2.9% in Q3 2021, buying an estimated $9.56K and bringing the position to 3,999 shares worth $299K. The position accounts for 0.13% of the portfolio, ranked #201.

Level Four Financial first reported a position in ARKG in Q1 2021 and has held it in 3 quarters since. The position peaked at $359K in Q2 2021. 470 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • Level Four Financial held 3,999 shares of ARK Genomic Revolution ETF worth $299K as of Q3 2021.
  • Level Four Financial bought 114 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $9.56K.
  • ARK Genomic Revolution ETF made up 0.13% of Level Four Financial's portfolio in Q3 2021, its #201 holding.
  • Level Four Financial first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 3 quarters since.
  • Level Four Financial's ARK Genomic Revolution ETF position peaked at $359K in Q2 2021.
  • 470 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Level Four Financial's 13F filing for Q3 2021, filed 12 Oct 2021.